Microsoft Word - Keays Medical Group

About 50% concordance seen between rCR and pCR in the dual therapy group. Review of breast imaging pre and post PST suggested that both invasive and in-situ disease responded well with dual therapy. Conclusions: Primary systemic therapy with dual-agent anti Her-2 blockade significantly increases pCR with a potential to increase BCS rates. ................
................